Complete

Shutting off cancer's energy supply

Cancer types:

General cancer research

Project period:

Research institute:

Institute for Research in Biomedicine (IRB Barcelona)

Award amount:

£199,253

Location:

Spain

Researcher Dr Angel Nebreda

Dr Angel Nebreda and his team aim to find out how cancer cells get their energy so that they can find ways to shut them down. 

Meet the scientist

Angel Nebreda is a group leader at the Institute for Research in Biomedicine in Barcelona. His team study how cells communicate and how these signals can play a role in cancer. 

The science

Cancer cells are known to obtain their energy through different mechanisms to normal cells so understanding how they do it could reveal new ways to develop targeted treatments. 

The team are particularly interested in a protein called p38-alpha MAPK, which they have begun to show plays a central role in the survival of cancer cells. They now want to study in greater detail exactly how this protein helps cancer cells to produce the energy they need to grow and divide and what happens to cancer cells if they try and block it off. 

Related projects

Andres Hidalgo Headshot

Active Spain

Lung cancer

How do cancer cells modify white blood cells to help tumours grow?

Researchers want to help immunotherapy work for more cancer patients by understanding how cancers hijack our immune system and preventing this happening 

Researcher: Dr Andrés Hidalgo

Understanding how cancer cells modify white blood cells to help tumours grow
Andrew Beekman and Team

Active United Kingdom

General cancer research

Can we stop cancer becoming resistant to chemotherapy?

Chemotherapy can sometimes stop working, so this project is hoping to better understand why and find ways to give more, better options to cancer patients.

Researcher: Dr Andrew Beekman

Stopping cancer becoming resistant to chemotherapy
Tim Elliott and Team

Active United Kingdom

General cancer research

Can we predict which patients will respond to immunotherapy?

This project hopes to open up exciting possibilities for personalised cancer treatment by finding how to predict which patients will respond best to treatment.

Researcher: Professor Tim Elliott

Finding ways to predict which patients will respond to immunotherapy
Share this page